Analytical validation of Illumina's TruSight Oncology 500 ctDNA assay

被引：4
|
作者：
Verhein, Kirsten C. [1 ]
Hariani, Gunjan [1 ]
Hastings, Stephanie B. [1 ]
Hurban, Patrick [1 ]
机构：
[1] Q Squared Solut, Morrisville, NC USA
来源：
CANCER RESEARCH | 2020年 / 80卷 / 16期
关键词：
D O I：
10.1158/1538-7445.AM2020-3114
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3114
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Validation of the TruSight Oncology 500 ctDNA Assay for Clinical Use
    Miller, M.
    King, S.
    Pattison, T.
    Eyring, K.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2023, 25 (11): : S28 - S28
  • [2] A Pilot Evaluation of the Workflow and Performance Characteristics of the Illumina TruSight Oncology 500 ctDNA v2 Assay
    Schneider, A.
    Campion, M.
    Galaria, S.
    Burns, T.
    Zheng, G.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2024, 26 (11): : S145 - S145
  • [3] Analytical Performance of the New Illumina TruSight Oncology 500 V2 Assay for Comprehensive Genomic Profiling
    Chou, D.
    Silhavy, J.
    Crain, B.
    Purdy, A.
    O'Brien, K.
    Singh, U.
    Agvanian, S.
    Valencia, N.
    Jacqueline, L.
    Rodriguez, J.
    Tim, R.
    LoCoco, J.
    Lang, S.
    Pawlowski, T.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2024, 26 (11): : S94 - S95
  • [4] Automation of the Illumina TruSight Oncology 500 ctDNA v2 Assay on the Hamilton Microlab NGS STAR MOA System
    Khan, N.
    Orr, B.
    Dargert, J.
    Burdette, J.
    Nguyen, T.
    Mossette, M.
    Rodriguez, K.
    Clark, K.
    Watson, L.
    Liao, S.
    Lang, S.
    LoCoco, J.
    Pawlowski, T.
    Parker, E.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2024, 26 (11): : S101 - S101
  • [5] ILLUMINA TruSight Oncology 500 Sequencing Panel Validation at A Large Community Based Hospital
    Kumar, Sandeep
    Schwartz, John
    Amin, Mitual
    Kilbourn, Jennifer
    Vue, Hlee
    Daraiseh, Susan
    Jabbar, Kausar
    LABORATORY INVESTIGATION, 2021, 101 (SUPPL 1) : 1066 - 1067
  • [6] ILLUMINA TruSight Oncology 500 Sequencing Panel Validation at A Large Community Based Hospital
    Kumar, Sandeep
    Schwartz, John
    Amin, Mitual
    Kilbourn, Jennifer
    Vue, Hlee
    Daraiseh, Susan
    Jabbar, Kausar
    MODERN PATHOLOGY, 2021, 34 (SUPPL 2) : 1066 - 1067
  • [7] A Robust and Reproducible ctDNA Assay Utilizing the Illumina TruSight Tumor 170 Panel
    Jager, A. C.
    Chou, D.
    Chuang, H.
    Crain, B.
    Du, T.
    Granger, G.
    Guo, Y.
    Haigis, R.
    Han, Y.
    Jiang, T.
    Johansen, S.
    Katz, S.
    Lu, L.
    Lococo, J.
    O'Brien, K.
    Purdy, A.
    Salmans, M.
    Pawlowski, T.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2017, 19 (06): : 1046 - 1046
  • [8] Efficient sample preparation with Covaris AFA® technology enhances confidence in Illumina® TruSight™Oncology 500 Assay
    Bhattacharyya, Debadeep
    Pal, Kasturi
    Daviso, Eugenio
    Thomann, Ulrich
    CANCER RESEARCH, 2022, 82 (12)
  • [9] Optimizing the Illumina TruSight Oncology 500 ctDNA v2 Workflow in a Clinical Lab with Automated Liquid Handling Systems
    Galaria, S.
    Schneider, A.
    Campion, M.
    Rossman, B.
    Soto, M.
    Hein, S.
    Tillmans, L.
    Ward, A.
    Niu, Z.
    Zheng, G.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2024, 26 (11): : S161 - S162
  • [10] Validation of TruSight™ Oncology Comprehensive (EU) assay
    Sementchenko, V.
    Harris, M.
    Haseley, N.
    Yazdanparast, A.
    Wenz, P.
    Dockter, J.
    Pawlowski, T.
    VIRCHOWS ARCHIV, 2022, 481 (SUPPL 1) : S58 - S59
12345